BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

856 related articles for article (PubMed ID: 29310800)

  • 1. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.
    Wang X; Khalil RA
    Adv Pharmacol; 2018; 81():241-330. PubMed ID: 29310800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and Biological Attributes of Matrix Metalloproteinases.
    Cui N; Hu M; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():1-73. PubMed ID: 28413025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Metalloproteinases in Remodeling of Lower Extremity Veins and Chronic Venous Disease.
    Chen Y; Peng W; Raffetto JD; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 147():267-299. PubMed ID: 28413031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
    Liu J; Khalil RA
    Prog Mol Biol Transl Sci; 2017; 148():355-420. PubMed ID: 28662828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease.
    Raffetto JD; Khalil RA
    Biochem Pharmacol; 2008 Jan; 75(2):346-59. PubMed ID: 17678629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.
    MacColl E; Khalil RA
    J Pharmacol Exp Ther; 2015 Dec; 355(3):410-28. PubMed ID: 26319699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation and involvement of matrix metalloproteinases in vascular diseases.
    Amin M; Pushpakumar S; Muradashvili N; Kundu S; Tyagi SC; Sen U
    Front Biosci (Landmark Ed); 2016 Jan; 21(1):89-118. PubMed ID: 26709763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional role of invariant water molecules in matrix metalloproteinases: a data-mining approach.
    Kumar H; Mandal SK; Gogoi P; Kanaujia SP
    J Biomol Struct Dyn; 2022; 40(20):10074-10085. PubMed ID: 34121627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metaloproteinases in vascular pathology.
    Simões G; Pereira T; Caseiro A
    Microvasc Res; 2022 Sep; 143():104398. PubMed ID: 35671836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinases in vascular physiology and disease.
    Siefert SA; Sarkar R
    Vascular; 2012 Aug; 20(4):210-6. PubMed ID: 22896663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.
    Benjamin MM; Khalil RA
    Exp Suppl; 2012; 103():209-79. PubMed ID: 22642194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of metalloproteinases in modification of extracellular matrix in invasive tumor growth, metastasis and angiogenesis].
    Fink K; Boratyński J
    Postepy Hig Med Dosw (Online); 2012 Sep; 66():609-28. PubMed ID: 23001203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases (MMPs), the main extracellular matrix (ECM) enzymes in collagen degradation, as a target for anticancer drugs.
    Jabłońska-Trypuć A; Matejczyk M; Rosochacki S
    J Enzyme Inhib Med Chem; 2016; 31(sup1):177-183. PubMed ID: 27028474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases in wound repair (review).
    Ravanti L; Kähäri VM
    Int J Mol Med; 2000 Oct; 6(4):391-407. PubMed ID: 10998429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.
    Kucukguven A; Khalil RA
    Curr Drug Targets; 2013 Mar; 14(3):287-324. PubMed ID: 23316963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinase contribution in management of cancer proliferation, metastasis and drug targeting.
    Abdel-Hamid NM; Abass SA
    Mol Biol Rep; 2021 Sep; 48(9):6525-6538. PubMed ID: 34379286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases (MMPs) in health and disease: an overview.
    Malemud CJ
    Front Biosci; 2006 May; 11():1696-701. PubMed ID: 16368548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of matrix metalloproteinases in the pathogenesis of diabetes mellitus and progression of diabetes retinopathy].
    Naduk-Kik J; Hrabec E
    Postepy Hig Med Dosw (Online); 2008 Sep; 62():442-50. PubMed ID: 18772849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.
    Chen Q; Jin M; Yang F; Zhu J; Xiao Q; Zhang L
    Mediators Inflamm; 2013; 2013():928315. PubMed ID: 23840100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases.
    Kim IS; Yang WS; Kim CH
    Curr Med Chem; 2023; 30(18):2075-2112. PubMed ID: 36017851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.